1. Home
  2. CRMT vs VYGR Comparison

CRMT vs VYGR Comparison

Compare CRMT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$12.46

Market Cap

103.5M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
VYGR
Founded
1981
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.5M
236.0M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
CRMT
VYGR
Price
$12.46
$3.96
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$29.50
$21.00
AVG Volume (30 Days)
197.3K
900.2K
Earning Date
03-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
N/A
EPS
N/A
N/A
Revenue
$1,390,932,000.00
$10,135,000.00
Revenue This Year
N/A
$33.19
Revenue Next Year
$4.57
$14.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.04
$2.65
52 Week High
$62.55
$5.55

Technical Indicators

Market Signals
Indicator
CRMT
VYGR
Relative Strength Index (RSI) 32.81 48.30
Support Level $11.04 $3.72
Resistance Level $13.87 $4.30
Average True Range (ATR) 0.95 0.21
MACD 0.31 -0.02
Stochastic Oscillator 47.53 51.75

Price Performance

Historical Comparison
CRMT
VYGR

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: